Cargando…
Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes
First-generation HCV protease inhibitors represent a milestone in antiviral therapy for chronic hepatitis C infection (CHC), but substantially increased rates of viral clearance are offset by increased rates of infection and infection-associated deaths, especially of patients with advanced liver dis...
Autores principales: | Spindelboeck, Walter, Horvath, Angela, Tawdrous, Monika, Schmerböck, Bianca, Zettel, Gabriele, Posch, Andreas, Streit, Andrea, Jurse, Petra, Lemesch, Sandra, Horn, Martin, Wuensch, Gerit, Stiegler, Philipp, Stauber, Rudolf E., Leber, Bettina, Stadlbauer, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777445/ https://www.ncbi.nlm.nih.gov/pubmed/26938078 http://dx.doi.org/10.1371/journal.pone.0150299 |
Ejemplares similares
-
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis
por: Horvath, A., et al.
Publicado: (2016) -
Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis
por: Stadlbauer, Vanessa, et al.
Publicado: (2017) -
Author Correction: Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis
por: Stadlbauer, Vanessa, et al.
Publicado: (2019) -
Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease
por: Lemesch, Sandra, et al.
Publicado: (2016) -
Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis
por: Horvath, Angela, et al.
Publicado: (2020)